Cyteir Therapeutics Inc (CYT) Financials

$3.01

$-0.01 (-0.33%)

As on 12-Apr-2024 09:30EDT

Market cap

$109 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	0.01	--
Cost of Revenue	0.83	1.38	0.48	0.35	0.01	--
Gross Profit	-0.83	-1.38	-0.48	-0.35	0.00	--
Operating Expenses	38.25	48.17	42.26	20.94	16.11	--
Operating Profit (EBIT)	-38.25	-48.17	-42.26	-20.94	-16.11	--
Other Income	2.14	2.11	0.13	--	--	--
Profit before Tax	-33.22	-46.06	-42.13	-20.82	-15.04	--
Provision for Tax	-2.33	-2.11	-0.48	-0.12	-1.06	--
Profit after Tax (Net Income)	-30.88	-43.95	-41.65	-20.82	-15.04	--
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-29.68	-46.06	-42.13	-20.82	-15.04	--

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	125.03	146.29	187.29	-48.03	-28.34	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.01	1.63	0.59	58.63	57.73	--
Current Liabilities	5.97	5.32	7.51	3.14	1.97	--
Total Liabilities	136.98	153.23	195.39	13.74	31.37	--

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.37	4.02	2.31	1.60	0.93	--
Current Assets	130.64	149.21	193.08	12.13	30.44	--
Total Assets	136.98	153.23	195.39	13.74	31.37	--
Total Debt*	0.02	0.89	--	--	--	--
Net Current Assets	124.67	143.89	185.57	8.99	28.47	--

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-42.53	-36.03	-18.54	-17.56	--
Cash Flow from Investing Activities	--	-0.31	-1.19	-0.85	-0.13	--
Cash from Financing Activities	--	0.24	216.01	1.43	36.89	--
Net Cash Inflow / Outflow	--	-42.60	178.79	--	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.87	-1.24	-1.19	-0.87	--	--
Cash EPS ($)	--	-1.22	-1.17	-0.86	--	--
Adjusted Book Value ($)	--	4.14	5.33	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.20	-1.03	-0.78	--	--
Free Cash Flow per Share ($)	--	-1.21	-1.06	-0.81	--	--

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-26.28	-59.81	54.53	--	--
ROE (%)	-23.76	-26.35	-59.81	54.53	--	--
ROA (%)	-20.29	-25.21	-39.83	-92.33	--	--
EBIT Margin (%)	--	--	--	--	-201,312.50	--
Net Margin (%)	-1,443.85	-2,084.02	-31,313.53	--	-188,050.00	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	-1.00	--	--
EBIT Growth (%)	23.34	-13.99	-101.78	-30.04	--	--
Net Profit Growth (%)	35.97	-5.53	-100.00	-38.41	--	--
EPS Growth (%)	36.66	-0.05	-0.36	--	--	--
Book Value Growth (%)	-20.41	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-1.33	-9.59	--	--	--
Price / Book Value	0.87	0.40	2.13	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.47	1.85	-5.02	--	--	--
Close Price ($)	2.84	1.65	11.37	--	--	--
High Price ($)	2.85	11.67	23.10	--	--	--
Low Price ($)	1.13	1.13	9.72	--	--	--
Market Cap ($ Cr)	108.71	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.01	--	--	--	--
Short term debt to equity ratio	0.00	0.01	--	--	--	--
Current Ratio	21.89	28.07	25.71	3.87	15.43	--
Quick Ratio	21.89	--	25.71	3.89	14.80	--
Interest Coverage	-33.21	-72.11	-88.22	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	2,050.00	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	7,487.63	--
Inventory Days	--	-10.09	-38.51	622.80	36,268.82	--
Payable days	--	386.90	1,324.51	1,192.01	17,328.43	--
Cash Conversion Cycle	--	--	--	--	26,428.01	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.